imatinib mesylate has been researched along with Cold Fingers, Hereditary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Butt, ZA; Howard, D; Ng, WL; Osman, K | 1 |
| Bibi, Y; Gottlieb, AB | 1 |
| Asano, Y; Hatano, M; Kawashima, T; Kinugawa, K; Nagai, R; Sato, S; Tamaki, Z; Tomita, M; Yao, A | 1 |
1 review(s) available for imatinib mesylate and Cold Fingers, Hereditary
| Article | Year |
|---|---|
A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis.
Topics: Benzamides; Fibrosis; Humans; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Raynaud Disease; Scleroderma, Localized; Scleroderma, Systemic; Skin | 2008 |
2 other study(ies) available for imatinib mesylate and Cold Fingers, Hereditary
| Article | Year |
|---|---|
Novel case of a scleroderma-mimicking syndrome associated with gastrointestinal stromal tumour.
Topics: Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Raynaud Disease; Scleroderma, Localized; Scleroderma, Systemic; Stomach Neoplasms | 2021 |
Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases.
Topics: Aged; Benzamides; Contracture; Dose-Response Relationship, Drug; Female; Hemorrhage; Humans; Imatinib Mesylate; Male; Middle Aged; Nail Diseases; Nails; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Range of Motion, Articular; Raynaud Disease; Scleroderma, Systemic; Skin; Treatment Outcome | 2012 |